Halozyme Therapeutics (HALO) Non-Current Deffered Revenue (2010 - 2023)
Halozyme Therapeutics (HALO) recorded Non-Current Deffered Revenue of $2.25 million in Q3 2023, down 20.5% from $2.83 million a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Halozyme Therapeutics (HALO) Non-Current Deffered Revenue (2010 - 2023) Analysis & Trends
Starting with Q4 2010, Halozyme Therapeutics' Non-Current Deffered Revenue history includes 46 quarters.
- Annual Non-Current Deffered Revenue has a five-year compound annual growth rate of -47.1% (FY2017 to FY2022).
- Across earlier years, Non-Current Deffered Revenue came in at $2.53 million in FY2021 (-37.2%), $4.03 million in FY2020 (+222.9%), $1.25 million in FY2019 (-75.1%) and $5.01 million in FY2018 (-90.8%).
- Quarterly Non-Current Deffered Revenue has ranged from $641,000 in Q3 2020 to $5.01 million in Q4 2018 over the past five years.
- On a year-over-year basis, Non-Current Deffered Revenue rose in two of the last eight quarters, with an average decline of 18.1%.
- Peak year-over-year performance for Non-Current Deffered Revenue in the last five years was growth of 294.7% in Q3 2021, against a decline of 90.8% in Q4 2018 at the low end.
- Per Business Quant, the preceding three quarters came in at $2.25 million (Q2 2023), $2.25 million (Q1 2023) and $2.25 million (Q4 2022).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | - |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | - |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | - |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | - |
| 10 | Halozyme Therapeutics | 12.53 Bn | 11.13 Bn | 401.83 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2023 | 2.25 Mn |
| Jun 30, 2023 | 2.25 Mn |
| Mar 31, 2023 | 2.25 Mn |
| Dec 31, 2022 | 2.25 Mn |
| Sep 30, 2022 | 2.83 Mn |
| Jun 30, 2022 | 2.74 Mn |
| Mar 31, 2022 | 2.03 Mn |
| Dec 31, 2021 | 2.53 Mn |
| Sep 30, 2021 | 2.53 Mn |
| Jun 30, 2021 | 4.03 Mn |
| Mar 31, 2021 | 4.03 Mn |
| Dec 31, 2020 | 4.03 Mn |
| Sep 30, 2020 | 641,000.00 |
| Dec 31, 2019 | 1.25 Mn |
| Dec 31, 2018 | 5.01 Mn |
| Sep 30, 2018 | 5.51 Mn |
| Jun 30, 2018 | 6.01 Mn |
| Mar 31, 2018 | 6.01 Mn |
| Dec 31, 2017 | 54.30 Mn |
| Sep 30, 2017 | 36.76 Mn |
API Access
Halozyme Therapeutics Non-Current Deffered Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=HALO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-deffered-revenue", "ticker": "HALO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=HALO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();